Xenical Rx-To-OTC Switch Filing Slated For 2005
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline will file for an Rx-to-OTC switch of Xenical (orlistat) a year earlier than expected
You may also be interested in...
Xenical Off-The-Market Switch Sought By Public Citizen
Public Citizen is calling for prescription weight-loss drug Xenical (120 mg orlistat) to be pulled from the market days after FDA issued an "approvable" letter for an OTC version
Xenical Off-The-Market Switch Sought By Public Citizen
Public Citizen is calling for prescription weight-loss drug Xenical (120 mg orlistat) to be pulled from the market days after FDA issued an "approvable" letter for an OTC version
Xenical Off-The-Market Switch Sought By Public Citizen
Public Citizen is calling for prescription weight-loss drug Xenical (120 mg orlistat) to be pulled from the market days after FDA issued an "approvable" letter for an OTC version